Milanova Tsveta
SEC insider (Form 3/4/5 filer). CIK 0001957180. Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO). 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.
Companies Milanova Tsveta has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Officer, Chief Commercial Officer
Milanova Tsveta
CIK: 0001957180
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AGIOS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirectPerformance share units
3K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
3K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect8.5K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect3.3K shares at avg. $34.71$113K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect1.2K shares at avg. $28.96$34K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect5.7K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect4K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect1.7K shares at avg. $28.96$49K - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
14K shares- - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
52K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise Performance share units | 3,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 3,000 | - | - | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 8,500 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 3,262 | $34.71 | $113,224 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 1,187 | $28.96 | $34,376 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 5,666 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 4,000 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 1,681 | $28.96 | $48,682 | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 14,000 | - | - | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 52,000 | - | - | Direct |
1-10 of 22 transactions